Parkinson’s disease mouse models in translational research

被引:0
|
作者
Paul M. A. Antony
Nico J. Diederich
Rudi Balling
机构
[1] University of Luxembourg,Luxembourg Centre for Systems Biomedicine (LCSB)
[2] Centre Hospitalier de Luxembourg,Department of Neuroscience
来源
Mammalian Genome | 2011年 / 22卷
关键词
Bacterial Artificial Chromosome; MPTP; Translational Research; Nigrostriatal Dopaminergic Neuron; Nonmotor Symptom;
D O I
暂无
中图分类号
学科分类号
摘要
Animal models with high predictive power are a prerequisite for translational research. The closer the similarity of a model to Parkinson’s disease (PD), the higher is the predictive value for clinical trials. An ideal PD model should present behavioral signs and pathology that resemble the human disease. The increasing understanding of PD stratification and etiology, however, complicates the choice of adequate animal models for preclinical studies. An ultimate mouse model, relevant to address all PD-related questions, is yet to be developed. However, many of the existing models are useful in answering specific questions. An appropriate model should be chosen after considering both the context of the research and the model properties. This review addresses the validity, strengths, and limitations of current PD mouse models for translational research.
引用
收藏
页码:401 / 419
页数:18
相关论文
共 50 条
  • [11] Translational Research on Stem Cells for Parkinson's Disease
    Parker, Graham C.
    STEM CELLS AND DEVELOPMENT, 2018, 27 (14) : 949 - 950
  • [12] Role of genomics in translational research for Parkinson's disease
    Sekiyama, Kazunari
    Takamatsu, Yoshiki
    Waragai, Masaaki
    Hashimoto, Makoto
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2014, 452 (02) : 226 - 235
  • [13] Conditional mouse models of Parkinson's disease
    Riess, O.
    Nuber, S.
    Petrasch-Parwez, E.
    Gellerich, F. N.
    Schmidt, T.
    Teismann, P.
    Schulz, J. B.
    Neumann, M.
    Fendt, M.
    Berg, D.
    Holzmann, C.
    Nguyen, H.
    Kuhn, M.
    Boy, J.
    Schmitt, I.
    Bornemann, A.
    Zimmermann, F.
    Kuhn, W.
    Prusinel, S. B.
    Dietz, K.
    Pichler, B.
    MOVEMENT DISORDERS, 2006, 21 : S477 - S477
  • [14] Parkinson's disease: Mechanisms, translational models and management strategies
    Raza, Chand
    Anjum, Rabia
    Shakeel, Noor ul Ain
    LIFE SCIENCES, 2019, 226 : 77 - 90
  • [15] Transgenic Mouse Models of Parkinson's Disease and Huntington's Disease
    Skaper, Stephen D.
    Giusti, Pietro
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2010, 9 (04) : 455 - 470
  • [16] Role of Animal Models in Parkinson's Disease (PD): What Role They Play in Preclinical Translational Research
    Srivastava, Rajnish
    Dilnashin, Hagera
    Kapoor, Devesh
    Aparna, Sai
    Heidarli, Elmira
    Singh, Surya Pratap
    Jain, Vivek
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2024, 23 (02) : 181 - 202
  • [17] MPTP Mouse Models of Parkinson's Disease: An Update
    Meredith, Gloria E.
    Rademacher, David J.
    JOURNAL OF PARKINSONS DISEASE, 2011, 1 (01) : 19 - 33
  • [18] Genetically engineered mouse models of Parkinson's disease
    Crabtree, Donna M.
    Zhang, Jianhua
    BRAIN RESEARCH BULLETIN, 2012, 88 (01) : 13 - 32
  • [19] Behavioral phenotyping of mouse models of Parkinson's disease
    Taylor, Tonya N.
    Greene, James G.
    Miller, Gary W.
    BEHAVIOURAL BRAIN RESEARCH, 2010, 211 (01) : 1 - 10
  • [20] Mouse models of atherosclerosis in translational research
    Ilyas, Iqra
    Little, Peter J.
    Liu, Zhiping
    Xu, Yanyong
    Kamato, Danielle
    Berk, Bradford C.
    Weng, Jianping
    Xu, Suowen
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2022, 43 (11) : 920 - 939